New Jersey S 3251: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2018-12-06)

State: New Jersey · Session: 218 · Bill: S 3251

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Greenstein, Linda R., Kean, Thomas H., Bucco, Anthony R.

View New Jersey S 3251 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.